Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for

Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopath

Calciphylaxis Clinical Trial

Official title:
Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy Followed by a Single Armed Extension Phase to Prospectively Observe Lesion Progression in the Presence of Sodium Thiosulfate Treatment

Status Terminated

Clinical Trial Summary

To evaluate the efficacy of Sodium Thiosulfate (STS) compared to placebo, in reducing analgesic requirement in subjects with calcific uremic arteriolopathy (CUA) during an initial 28-day treatment phase.

Clinical Trial Description

Efficacy of Sodium Thiosulfate (STS) compared to placebo, in reducing analgesic requirement in subjects with calcific uremic arteriolopathy (CUA) during an initial 28-day treatment phase. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02527213
Study type	Interventional
Source	Luitpold Pharmaceuticals
Contact
Status	Terminated
Phase	Phase 3
Start date	January 30, 2015
Completion date	August 29, 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01578382` - Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU)
Active, not recruiting	`NCT04592640` - Stem Cells for Uremic Calciphylaxis Patients	N/A
Terminated	`NCT03319914` - Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate
Recruiting	`NCT06065852` - National Registry of Rare Kidney Diseases
Terminated	`NCT03150420` - A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients	Phase 3
Completed	`NCT02790073` - Phase 2 Study With SNF472 in Calciphylaxis Patients	Phase 2
Recruiting	`NCT03146793` - The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With Calciphylaxis, From a National Cohort	N/A
Completed	`NCT02278692` - Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy	N/A
Completed	`NCT02854046` - Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome
Recruiting	`NCT03032835` - Partners Calciphylaxis Biobank
Completed	`NCT01289626` - Efficacy of Lanthanum Carbonate in Calciphylaxis	Phase 1
Recruiting	`NCT06283589` - The SEAPORT 1 Study: Evaluation of the Safety and Tolerability of INZ-701 in Adults With End-Stage Kidney Disease Undergoing Hemodialysis	Phase 1
Completed	`NCT04195906` - Phase 3 Study of SNF472 for Calciphylaxis	Phase 3
Recruiting	`NCT02635373` - European Calciphylaxis Registry Network	N/A
Recruiting	`NCT05018221` - Better Evidence and Translation for Calciphylaxis	Phase 3